| Shareholder | |||||
|---|---|---|---|---|---|
Frazier Life Sciences Management, LP | 7.40% | 7.61M | -- | +7.61M | |
TPG Capital, L.P. | 6.68% | 6.88M | -- | +6.88M | |
venBio LLC | 5.75% | 5.91M | -- | +5.91M | |
Logos Global Management, L.P. | 5.27% | 5.43M | -- | +5.43M | |
BlackRock, Inc. | 5.12% | 5.27M | 4.30% | +4.83M | |
Franklin Templeton Inc. | 4.81% | 4.95M | 3.39% | +584.03K | |
Paradigm Biocapital Advisors LP | 4.81% | 4.95M | -- | +4.95M | |
Vanguard Capital Management, LLC | 4.60% | 4.73M | 0.13% | +2.21M | |
Propel Bio Management, LLC | 3.92% | 4.03M | 0.97% | +1.43M | |
Marshall Wace LLP | 3.66% | 3.77M | 1.75% | +2.75M | |
Dialectic Capital Management, LP | 3.40% | 3.49M | 3.17% | +0 | |
State Street Investment Management | 2.86% | 2.95M | 2.38% | +2.69M | |
VR Management, LLC | 2.67% | 2.75M | -- | +2.75M | |
Vivo Capital, LLC | 2.67% | 2.75M | <0.01% | +0 | |
Janus Henderson Group Ltd. | 2.67% | 2.75M | -- | +2.75M | |
Eventide Asset Management, LLC | 2.16% | 2.22M | -- | +2.22M | |
Geode Capital Management, LLC | 2.00% | 2.06M | 0.83% | +1.44M | |
Alyeska Investment Group, L.P. | 1.87% | 1.93M | 1.87% | +1.93M | |
Contrarian Alpha Management, LLC | 1.62% | 1.67M | 1.51% | +0 | |
Patrick Callahan | 1.49% | 1.53M | 1.39% | +0 |
